Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Chronic Migraine With Erenumab Alone or as an Add on Therapy; a Real World Prospective Observational Study

NCT04152434 is registered in ClinicalTrials.gov with Clinique des Céphalées de Montréal as lead sponsor.

NCT NCT04152434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04152434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Chronic Migraine With Erenumab Alone or as an Add on Therapy; a Real World Prospective Observational Study
Lead sponsor
Clinique des Céphalées de Montréal
Phase
Observational
Overall status
Completed
Start date
April 1, 2019
Completion date
August 30, 2019
Enrollment
158 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory chronic migraine